Daiichi Sankyo Co Ltd是一家主要从事药品生产和销售业务的日本公司。该公司从事药物的研究、开发、制造和销售业务，并在日本、美国、欧洲和其他市场提供药物生产的中间体和基础材料。该公司还从事非处方药和疫苗的研究、开发、生产和销售业务，提供人力 ...

Daiichi Sankyo has launched its oncolytic virus therapy Delytact in Japan – its first world market – as a treatment for malignant glioma, an aggressive form of brain cancer.

There has been another twist in the road for the ongoing legal battle between Seagen and Daiichi Sankyo over patent rights for antibody-drug conjugate (ADC) Enhertu. The US Patent and Trademark ...